FDA Drug recall D-166-2013
Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg
- FDA Drug
- Class I
- terminated
- Published 2013-02-27
On 2013-02-27 the FDA classified a Class I recall of Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg by Mylan Institutional D B A Udl Laboratories, citing superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.
Read the official FDA Drug notice
| Agency | FDA Drug |
|---|---|
| Recall number | D-166-2013 |
| Classification | Class I |
| Status | terminated |
| Initiated | 2012-12-14 |
| Published | 2013-02-27 |
| Last updated | 2026-09-13 11:51 UTC |
| Company | Mylan Institutional D B A Udl Laboratories |
| Distribution | US |
Product
Hydrocodone Bitartrate and Acetaminophen Tablets, USP, 10 mg/500 mg; 100 Tablets (5 x 20), 5 cards each containing 20 blistered tablets per carton, Rx only; Manufactured for: Qualitest Pharmaceuticals, Huntsville, AL 35811, Pkg by & Distributed by UDL Laboratories, Inc., Rockford, IL 61103; NDC 51079-254-21.
Reason
Superpotent (Multiple Ingredient) Drug: Oversized tablets resulting in superpotent assays of both the hydrocodone and acetaminophen components.
Identifiers
| code_info | Lot #: 3037841, 3040859, 3042573, Exp 12/13 |
|---|
Status history
No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.
Source
Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-166-2013%22
RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.